First, the relationship between RMC-6236 concentration in tumors (tumor PK) and RAS pathway inhibition, as measured by human DUSP6 levels (tumor PD), in xenograft tumors was investigated by compiling a data set from multiple PK/PD studies on each model (Supplementary Table S6). Here, DUSP6 is linked to neoplasm.